Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 5/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 5/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 5/20 | 0.47 |
| ▸ | SUV39H2 | Q9H5I1 | 11/20 | 0.40 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.36 |
| ▸ | SYK | P43405 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12119836 | 0.94 | AURKA (0.51) | AURKAPDPK1AURKBSUV39H2EIF2AK4 | |
| SCHEMBL12119825 | 0.90 | AURKA (0.58) | AURKAPDPK1AURKBSUV39H2EIF2AK4 | |
| SCHEMBL16966467 | 0.90 | AURKA (0.36) | AURKAPDPK1AURKB | |
| SCHEMBL13354875 | 0.89 | AURKA (0.52) | AURKAPDPK1AURKBSUV39H2EIF2AK4 | |
| SCHEMBL12119798 | 0.88 | JAK3 (0.49) | AURKAPDPK1AURKBSUV39H2JAK3 | |
| SCHEMBL12119839 | 0.86 | AURKA (0.54) | AURKAPDPK1AURKBSUV39H2EIF2AK4 | |
| SCHEMBL13354730 | 0.85 | PDPK1 (0.56) | AURKAPDPK1AURKBEIF2AK4BTK | |
| SCHEMBL12119823 | 0.84 | AURKA (0.63) | AURKAPDPK1AURKBSUV39H2EIF2AK4 | |
| SCHEMBL16966439 | 0.83 | AURKA (0.38) | AURKAPDPK1AURKB | |
| SCHEMBL1318715 | 0.82 | AURKA (0.43) | AURKAPDPK1AURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2362775-B1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20110275611-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC | 2011-11-10 | — | — | US | disclosed |
| US-20110275611-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275611-A1 | CHEMICAL COMPOUNDS | PDK1, PDK2, PDK3 | AURKA 298/4885PDPK1 12/4885AURKB 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.